Manuela Monti

1.1k total citations
47 papers, 757 citations indexed

About

Manuela Monti is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Manuela Monti has authored 47 papers receiving a total of 757 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 17 papers in Pulmonary and Respiratory Medicine and 11 papers in Epidemiology. Recurrent topics in Manuela Monti's work include Radiopharmaceutical Chemistry and Applications (9 papers), Neuroendocrine Tumor Research Advances (9 papers) and Neuroblastoma Research and Treatments (9 papers). Manuela Monti is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (9 papers), Neuroendocrine Tumor Research Advances (9 papers) and Neuroblastoma Research and Treatments (9 papers). Manuela Monti collaborates with scholars based in Italy, France and Germany. Manuela Monti's co-authors include Giovanni Paganelli, Stefano Severi, Maddalena Sansovini, Anna Sarnelli, Silvia Nicolini, Annarita Ianniello, Emanuela Scarpi, Valentina Di Iorio, Lisa Bodei and Federica Matteucci and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and British Journal of Cancer.

In The Last Decade

Manuela Monti

42 papers receiving 751 citations

Peers

Countries citing papers authored by Manuela Monti

Since Specialization

Citations

This map shows the geographic impact of Manuela Monti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuela Monti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuela Monti more than expected).

Fields of papers citing papers by Manuela Monti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuela Monti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuela Monti. The network helps show where Manuela Monti may publish in the future.

Co-authorship network of co-authors of Manuela Monti

This figure shows the co-authorship network connecting the top 25 collaborators of Manuela Monti. A scholar is included among the top collaborators of Manuela Monti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuela Monti. Manuela Monti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	How Regulation 536/2014 Is Changing Academic Research with Therapeutic Radiopharmaceuticals: A Local Experience 2025 ·Pharmaceuticals ·Valentina Di Iorio, Stefano Boschi, (unknown), Maddalena Sansovini, Federica Matteucci, Carla Masini, Manuela Monti	0
2	Radioligand therapies in cancer: mapping the educational landscape in Europe 2023 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), (unknown), Maddalena Sansovini, Manuela Monti, Giovanni Paganelli, Ignasi Gich, Albert Flotats, Paola Anna Erba, Jean‐Yves Blay, Christian la Fougère, Hendrik Van Poppel, (unknown), Ken Herrmann, Alessandro Giordano, Tamás Györke, Christophe M. Deroose, Federica Matteucci, Ignasi Carrió	2
3	A New Approach for a Safe and Reproducible Seeds Positioning for Diffusing Alpha-Emitters Radiation Therapy of Squamous Cell Skin Cancer: A Feasibility Study 2022 ·Cancers ·Giacomo Feliciani, (unknown), (unknown), (unknown), Manuela Monti, Ignazio Stanganelli, Yona Keisari, I. Kelson, Aron Popovtzer, Antonino Romeo, Anna Sarnelli	5
4	Circulating androgen receptor gene amplification and resistance to 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: results of a Phase 2 trial 2021 ·British Journal of Cancer ·Ugo De Giorgi, Maddalena Sansovini, Stefano Severi, Silvia Nicolini, Manuela Monti, Giorgia Gurioli, Flavia Foca, Chiara Casadei, Vincenza Conteduca, Monica Celli, Valentina Di Iorio, Daniele Calistri, Federica Matteucci, Finn Edler von Eyben, Gerhardt Attard, Giovanni Paganelli	20
5	Heterogeneity of bone metastases as an important prognostic factor in patients affected by oestrogen receptor-positive breast cancer. The role of combined [18F]Fluoroestradiol PET/CT and [18F]Fluorodeoxyglucose PET/CT 2021 ·European Journal of Radiology ·Gianluca Bottoni, Arnoldo Piccardo, Francesco Fiz, Giacomo Siri, Federica Matteucci, Andrea Rocca, Oriana Nanni, Manuela Monti, Étienne Brain, Jean‐Louis Alberini, Bassam Dib, Gian Mauro Sacchetti, Chiara Saggia, Valentina Rossi, Nadia Harbeck, Rachel Wuerstlein, Tom Degenhardt, Andrea DeCensi, Gian Andrea Rollandi, Alessandra Gennari	18
6	Theragnostic in neuroendocrine tumors 2021 ·The Quarterly Journal of Nuclear Medicine and Molecular Imaging ·Irene Marini, Maddalena Sansovini, Alberto Bongiovanni, Silvia Nicolini, Ilaria Grassi, (unknown), Manuela Monti, Valentina Di Iorio, (unknown), Paola Caroli, Anna Sarnelli, Giovanni Paganelli, Stefano Severi	4
7	Role of Hyperbaric Oxygenation Plus Hypofractionated Stereotactic Radiotherapy in Recurrent High-Grade Glioma 2021 ·Frontiers in Oncology ·(unknown), (unknown), (unknown), (unknown), (unknown), P. Cenni, (unknown), (unknown), Elisa Neri, (unknown), (unknown), Manuela Monti, Flavia Foca, Anna Tesei, Chiara Arienti, Anna Sarnelli, Giovanni Martinelli, (unknown)	6
8	68Ga-PSMA-11 PET/CT-Guided Stereotactic Body Radiation Therapy Retreatment in Prostate Cancer Patients with PSA Failure after Salvage Radiotherapy 2020 ·Biomedicines ·Paola Caroli, (unknown), Ugo De Giorgi, (unknown), Monica Celli, Emanuela Scarpi, Manuela Monti, Valentina Di Iorio, Anna Sarnelli, Giovanni Paganelli, Federica Matteucci, Antonino Romeo	11
9	177Lu-PRRT in advanced gastrointestinal neuroendocrine tumors: 10-year follow-up of the IRST phase II prospective study 2020 ·European Journal of Nuclear Medicine and Molecular Imaging ·Giovanni Paganelli, Maddalena Sansovini, Silvia Nicolini, Ilaria Grassi, Toni Ibrahim, (unknown), Valentina Di Iorio, Manuela Monti, Emanuela Scarpi, Alberto Bongiovanni, Mattia Altini, Luca Urso, Corrado Cittanti, Federica Matteucci, Stefano Severi	24
10	How Many Cancer Clinical Trials Can a Clinical Research Coordinator Manage? The Clinical Research Coordinator Workload Assessment Tool 2020 ·JCO Oncology Practice ·Francesca Fabbri, (unknown), Patrizia Serra, Bernadette Vertogen, Daniele Andreis, Monia Dall’Agata, (unknown), Valentina Gallá, Ilaria Massa, (unknown), Manuela Monti, (unknown), (unknown), Angela Ragazzini, (unknown), (unknown), Linda Valmorri, Chiara Zingaretti, F. Zumaglini, (unknown)	7
11	Dosimetry and safety of 177Lu PSMA-617 along with polyglutamate parotid gland protector: preliminary results in metastatic castration-resistant prostate cancer patients 2020 ·European Journal of Nuclear Medicine and Molecular Imaging ·Giovanni Paganelli, Anna Sarnelli, Stefano Severi, Maddalena Sansovini, Maria Luisa Belli, Manuela Monti, Flavia Foca, Monica Celli, Silvia Nicolini, Elisa Tardelli, Irene Marini, Federica Matteucci, Melchiore Giganti, Valentina Di Iorio, Ugo De Giorgi	45
12	Ricerca clinica: abbastanza giocatori per vincere la partita? 2019 ·Recenti Progressi in Medicina ·Celeste Cagnazzo, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Manuela Monti	4
13	Dosimetry of 177Lu-PSMA-617 after Mannitol Infusion and Glutamate Tablet Administration: Preliminary Results of EUDRACT/RSO 2016-002732-32 IRST Protocol 2019 ·Molecules ·Anna Sarnelli, Maria Luisa Belli, Valentina Di Iorio, Emilio Mezzenga, Monica Celli, Stefano Severi, Elisa Tardelli, Silvia Nicolini, Devil Oboldi, Licia Uccelli, Corrado Cittanti, Manuela Monti, Mahila Ferrari, Giovanni Paganelli	35
14	Coordinatori di ricerca clinica: una risorsa indispensabile 2019 ·Recenti Progressi in Medicina ·Celeste Cagnazzo, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Manuela Monti	8
15	Clinical evidence of abscopal effect in cutaneous squamous cell carcinoma treated with diffusing alpha emitters radiation therapy: a case report 2019 ·Journal of Contemporary Brachytherapy ·(unknown), Giacomo Feliciani, (unknown), Manuela Monti, (unknown), Anna Sarnelli, Antonino Romeo, I. Kelson, Yona Keisari, Aron Popovtzer, Toni Ibrahim, Giovanni Paganelli, Ignazio Stanganelli	39
16	Phase Ib dose-finding trial of lapatinib plus pegylated liposomal doxorubicin in advanced HER2-positive breast cancer 2017 ·Cancer Chemotherapy and Pharmacology ·Andrea Rocca, Lorenzo Cecconetto, Alessandro Passardi, (unknown), Daniele Andreis, Manuela Monti, Roberta Maltoni, Samanta Sarti, Elisabetta Pietri, Alessio Schirone, Francesco� Fabbri, Caterina Donati, Oriana Nanni, Anna Fedeli, Marina Faedi, Dino Amadori	15
17	ERA-Net TRANSCAN JTC 2011: Critical aspects of the startup procedures of an International Academic Clinical trial (ET-FES), funded by the European Community (EC) and coordinated by an Italian Institution. 2016 ·Annals of Oncology ·Manuela Monti, (unknown), Oriana Nanni, Arnoldo Piccardo, (unknown), Étienne Brain, (unknown), Nadia Harbeck, Rachel Wuerstlein, (unknown), Domenico Franco Merlo, Tom Degenhardt, Alfredo Cesario, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Alessandra Gennari	0
18	Feasibility and utility of re-treatment with 177Lu-DOTATATE in GEP-NENs relapsed after treatment with 90Y-DOTATOC 2015 ·European Journal of Nuclear Medicine and Molecular Imaging ·Stefano Severi, Maddalena Sansovini, Annarita Ianniello, Lisa Bodei, Silvia Nicolini, Toni Ibrahim, Valentina Di Iorio, (unknown), Paola Caroli, Manuela Monti, Giovanni Paganelli	51
19	Doxorubicin, Paclitaxel and Gemcitabine: a Phase I Study of a New Sequential Treatment in Stage III B - IV Breast Cancer 2003 ·Journal of Chemotherapy ·Toni Ibrahim, M. Fabbri, Giovanni Luca Frassineti, Wainer Zoli, Manuela Monti, Luca Ricotti, D. Amadori	5
20	Clinical evidence of neuroendocrine differentiation in a patient with prostate cancer and bone marrow micrometastases 2001 ·British Journal of Urology ·Alessandro Sciarra, (unknown), Orazio Schillaci, Manuela Monti, (unknown), F. Di Silverio	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact